Stockreport

Crinetics Pharmaceuticals Third Quarter 2024 Earnings: US$0.96 loss per share (vs US$1.01 loss in 3Q 2023) [Yahoo! Finance]

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report
PDF Looking ahead, revenue is forecast to grow 68% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Biotechs industry in the US. Perform [Read more]